PsychRounds: The Psychiatry Podcast
by Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 23 chart positions in 23 markets.
By chart position
- 🇨🇦CA · Medicine#7730K to 100K
- 🇺🇸US · Medicine#9530K to 100K
- 🇩🇪DE · Medicine#1185K to 30K
- 🇧🇷BR · Medicine#1401K to 10K
- 🇰🇷KR · Medicine#1411K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
92K to 317K🎙 ~2x weekly·109 episodes·Last published 3w ago - Monthly Reach
Unique listeners across all episodes (30 days)
183K to 634K🇨🇦16%🇺🇸16%🇨🇱16%+20 more - Active Followers
Loyal subscribers who consistently listen
73K to 254K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 13 epsHosts
Recent guests
Recent episodes
Modafinil (Provigil)
Jun 3, 2026
19m 36s
Naltrexone
May 20, 2026
16m 10s
Placebo Effect and Response in Psychiatry
May 6, 2026
22m 14s
Amantadine (Symmetrel)
Apr 8, 2026
17m 01s
VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
Mar 21, 2026
17m 19s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/3/26 | Modafinil (Provigil)✨ | Modafinilpsychiatry+4 | — | ModafinilTeva Pharmaceuticals USA, Inc.+5 | — | ModafinilProvigil+5 | — | 19m 36s | |
| 5/20/26 | Naltrexone✨ | medicationpsychiatry+3 | — | NaltrexoneNCBI+2 | — | Naltrexonepsychiatry+3 | — | 16m 10s | |
| 5/6/26 | Placebo Effect and Response in Psychiatry✨ | placebo effectpsychiatry+3 | — | PubMedNCBI+2 | — | placebo effectpsychiatry+3 | — | 22m 14s | |
| 4/8/26 | Amantadine (Symmetrel)✨ | Amantadinepsychiatry+3 | — | AmantadineSymmetrel | — | AmantadineSymmetrel+3 | — | 17m 01s | |
| 3/21/26 | VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)✨ | tardive dyskinesiaVMAT2 inhibitors+3 | — | Valbenazine (Ingrezza)Deutetrabenazine (Austedo)+3 | — | tardive dyskinesiaVMAT2 inhibitors+3 | — | 17m 19s | |
| 2/25/26 | A DSM Conversation with Dr. Allen Frances✨ | DSMPsychiatry+3 | Dr. Allen Frances | DSM IIIDSM IV | — | DSMAllen Frances+3 | — | 55m 50s | |
| 1/28/26 | Topiramate (Topamax)✨ | psychiatrymedication+3 | — | TopiramateTopamax+2 | — | TopiramateTopamax+3 | — | 15m 19s | |
| 1/14/26 | What Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa✨ | psychiatric illnesspsychotherapy+3 | Dr. Mark Ruffalo | University of Central Florida College of MedicineTufts University School of Medicine+2 | — | psychiatric illnesspsychotherapy+3 | — | 54m 32s | |
| 12/31/25 | Lorazepam (Ativan)✨ | benzodiazepinepsychiatry+3 | — | LorazepamAtivan+3 | — | LorazepamAtivan+5 | — | 14m 27s | |
| 12/17/25 | The Vitamin Series: Iron Deficiency in Psychiatry✨ | iron deficiencymental health+3 | — | NCBIScienceDirect+3 | — | iron deficiencypsychiatry+4 | — | 25m 24s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 12/3/25 | Nutritional Psychiatry with Dr. Laura Lachance✨ | Nutritional PsychiatryMental Health+3 | Dr. Laura Lachance | EASe-GAD trialAntidepressant Food Score+1 | — | Nutritional PsychiatryAntidepressant Food Score+4 | — | 49m 18s | |
| 11/19/25 | Stress, Culture, and Determinism with Dr. Robert Sapolsky✨ | stressculture+3 | Dr. Robert Sapolsky | Stanford UniversityInstitute of Primate Research+3 | — | stressculture+5 | — | 1h 03m 08s | |
| 11/5/25 | SSRIs Revisited: The 100th Episode✨ | SSRIsmental health+3 | — | Selective Serotonin Reuptake Inhibitors | — | SSRIsSelective Serotonin Reuptake Inhibitors+3 | — | 32m 53s | |
| 10/29/25 | Alprazolam (Xanax) | Welcome back! Today we have a very special episode on Alprazolam, brand-name Xanax. This benzodiazepine is one of the most commonly-prescribed and sought out psychotropic medications. https://www.ncbi.nlm.nih.gov/books/NBK538165/https://pmc.ncbi.nlm.nih.gov/articles/PMC6769182/ https://pmc.ncbi.nlm.nih.gov/articles/PMC5846112/https://pubmed.ncbi.nlm.nih.gov/6141930/https://pubmed.ncbi.nlm.nih.gov/17514187/ | — | ||||||
| 10/22/25 | Climate Change and Mental Health with Dr. Ferdnand Osuagwu | Join us today for an episode on the impact of climate change on mental health. We'll be exploring concepts like eco-anxiety, advocacy, the impact of nuclear war and practical tips. We're joined by guest Dr. Ferdnand Osuagwu, who was the former Chair of the Caucus on Climate Change and Mental Health of the American Psychiatric Association (APA) and founder of the Ferdnand Foundation International, an organization dedicated to underserved and marginalized populations and with a particular emphasis on addressing their needs in the areas of health, education, climate change, social justice and resource mobilization. Ferdnand Foundation Website: https://ferdnandfoundation.org/Ferdnand Foundation Youtube Channel: https://www.youtube.com/@FerdnandFoundation/featured | — | ||||||
| 10/15/25 | Introduction to Benzodiazepines | Today, we are talking about a very popular, yet controversial class of medications - the Benzodiazepines . Let's look at their mechanism of action, clinical indications, pharmacology, risks, withdrawal syndromes, and prescribing guidance. And of course, we'll be tackling the question: what are the risks and benefits of long-term use? References: https://pubmed.ncbi.nlm.nih.gov/30098211/https://pubmed.ncbi.nlm.nih.gov/32252539/https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rateshttps://aapp.org/guideline/benzohttps://pubmed.ncbi.nlm.nih.gov/40526204/https://pmc.ncbi.nlm.nih.gov/articles/PMC6097846/https://www.ncbi.nlm.nih.gov/books/NBK470159/https://www.cambridge.org/core/journals/advances-in-psychiatric-treatment/article/benzodiazepines-for-anxiety-disorders-maximising-the-benefits-and-minimising-the-risks/43A366723CD1B3616BAB08F69FF65A88 | — | ||||||
| 10/8/25 | Introduction to Anxiety Disorders | Welcome to an introductory episode on anxiety disorders as requested by a long-time listener. References:https://pmc.ncbi.nlm.nih.gov/articles/PMC5832062/https://pmc.ncbi.nlm.nih.gov/articles/PMC5573565/https://deepblue.lib.umich.edu/bitstream/handle/2027.42/175862/Nesse%20Anxiety%20Disorders%20in%20Evolutionary%20Perspective%202022.pdf?sequence=1 | — | ||||||
| 10/1/25 | Loxapine (Loxitane) Revisited with Dr. Jonathan Meyer | Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice. This is a revision of an earlier episode, after Dr. Bradley Miller chatted with Dr. Jonathan Meyer at the 2025 APA Conference. Dr. Meyer joins us at the beginning to provide an addendum to the original episode. | — | ||||||
| 9/24/25 | Pregabalin (Lyrica) | Welcome back! Today, we will be talking about Pregabalin, brand-name Lyrica, a similar medication to Gabapentin, and we will specifically be focusing on its use in psychiatry. What are its benefits and drawbacks compared to Gabapentin? Sources:- https://pubmed.ncbi.nlm.nih.gov/33563173/- https://pubmed.ncbi.nlm.nih.gov/39989902/- https://pmc.ncbi.nlm.nih.gov/articles/PMC3699256/- https://pubmed.ncbi.nlm.nih.gov/33563173/ | — | ||||||
| 9/17/25 | Gabapentin (Neurontin) | Welcome back! Today, we will be talking about Gabapentin, brand-name Neurontin, one of the most commonly-prescribed medications in the United States, and we will specifically be focusing on its use in psychiatry. It is commonly prescribed for anxiety disorders, alcohol use disorder, and sometimes even bipolar disorder! But what does the evidence say?Sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC3619699/#:~:text=The%20FDA%20approved%20gabapentin%20enacarbil,legs%20syndrome%20(RLS)%20symptoms.https://journals.lww.com/intclinpsychopharm/Abstract/2017/01000/Pregabalin_for_generalized_anxiety_disorder__an.8.aspxhttps://pmc.ncbi.nlm.nih.gov/articles/PMC9507147/https://pmc.ncbi.nlm.nih.gov/articles/PMC4732322/https://pubmed.ncbi.nlm.nih.gov/9263379/https://pubmed.ncbi.nlm.nih.gov/28988943/https://www.cdc.gov/mmwr/volumes/71/wr/mm7119a3.htm | — | ||||||
| 9/10/25 | Trauma and The Neurosequential Model of Therapeutics with Dr. Bruce Perry | Welcome back! Today, we have renowned guest Dr. Bruce Perry, one of the world's most influential child psychiatrists, to talk to us about his approach to trauma. We will go over Dr. Perry's Neurosequential Model of Therapeutics, which integrates neuroscience with child development. Dr. Perry is also a respected author, co-writing books like The Boy Who Was Raised As a Dog, Born for Love: Why Empathy is Essential and Endangered, as well as What Happened to You? Conversations on Trauma, Resilience and Healing.Dr. Perry's Website: https://www.bdperry.com/Dr. Perry's Books: https://www.amazon.com/Books-Bruce-Perry/s?rh=n%3A283155%2Cp_27%3ABruce%2BPerryDr. Perry's Youtube Channel: https://www.youtube.com/@infonmn326 | — | ||||||
| 9/3/25 | The Spectrum of Mood Disorders with Dr. Chris Aiken | Welcome Back! Today we are interviewing Dr. Chris Aiken, Editor-in-Chief of the Carlat Psychiatry Report. We will be speaking about the broad spectrum of mood disorders, how Bipolar Disorder is different from Manic-Depressive Illness, affective temperaments, non-pharmacological treatments, and more! Dr. Aiken's new book, Difficult to Treat Depression, will be released later this year (2025). Sources:Akiskal Article: https://pubmed.ncbi.nlm.nih.gov/10550853/Dr. Aiken's Website: https://chrisaikenmd.com/Dr. Aiken's Twitter: https://x.com/chrisaikenmdTEMPS-A Scale: https://chrisaikenmd.com/wp-content/uploads/2024/10/tempsa.pdf | — | ||||||
| 8/27/25 | Pramipexole (Mirapex) in Treatment Resistant Depression | Welcome back! Today, we will review Pramipexole (Mirapex) and take a look at a recent study published in The Lancet Psychiatry regarding its use in treatment-resistant depression.References:https://pubmed.ncbi.nlm.nih.gov/17854248/https://pmc.ncbi.nlm.nih.gov/articles/PMC10034846/https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(25)00194-4/fulltext | — | ||||||
| 8/20/25 | Psychedelics, Consciousness, and Buddhist Practices with Dr. Charles Raison | Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today's episode is with Dr. Charles Raison, a psychiatrist. This is the second part of our discussion, and we’re going to be looking at novel treatments like psychedelics and their impact on consciousness as well as whole-body hyperthermia and practices from Tibetan Buddhism. Dr. Raison co-authored the 2017 book The New Mind-Body Science of Depression with the late Dr. Vladimir Maletic, who sadly passed away in December 2024. Find the book here: https://www.amazon.com/New-Mind-Body-Science-Depression/dp/0393706664Psych Congress Discount Code: PSYCHROUNDSConference Website: https://www.hmpglobalevents.com/psych-congressIn Memoriam of Dr. Maletic: https://www.hmpglobalevents.com/faculty/Psych-Congress/620Raison Lab: https://raisonresearch.psychiatry.wisc.edu/Sources:- https://pubmed.ncbi.nlm.nih.gov/35370864/- https://pubmed.ncbi.nlm.nih.gov/27172277/ | — | ||||||
| 8/13/25 | The Biological and Evolutionary Underpinnings of Depression with Dr. Charles Raison | Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today's episode is with Dr. Charles Raison, a psychiatrist who has done extensive research on the biological and evolutionary underpinnings of depression, which includes inflammation and the neuroendocrine system. Dr. Raison co-authored the 2017 book The New Mind-Body Science of Depression with the late Dr. Vladimir Maletic, who sadly passed away in December 2024. Find the book here: https://www.amazon.com/New-Mind-Body-Science-Depression/dp/0393706664Psych Congress Discount Code: PSYCHROUNDSConference Website: https://www.hmpglobalevents.com/psych-congressIn Memoriam of Dr. Maletic: https://www.hmpglobalevents.com/faculty/Psych-Congress/620Raison Lab: https://raisonresearch.psychiatry.wisc.edu/Sources:https://pmc.ncbi.nlm.nih.gov/articles/PMC3285451/https://pubmed.ncbi.nlm.nih.gov/12944327/ | — | ||||||
Showing 25 of 49
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
25 placements across 23 markets.
Chart Positions
25 placements across 23 markets.